SlideShare a Scribd company logo
Cholera
Dr. Shubhangi S. Kshirsagar
Assistant professor
Department of Swasthavritta & Yoga
drssksagar@gmail.com
Cholera is an acute diarrhoeal disease caused by
V. Cholerae O1 (classical or El Tor} and O139.
It is now commonly due to the El Tor biotype and
O139.
Cases range from symptomless to severe infections.
The majority of infections are mild or asymptomatic.
Typical cases are characterized by the sudden onset of
profuse, effortless, watery diarrhoea followed by
vomiting, rapid dehydration, muscular cramps and
suppression of urine.
Cholera
2
Dr. Shubhangi Kshirsagar
Epidemiological
determinant
3
Dr. Shubhangi Kshirsagar
1. Agent factors
a. Agent - V. cholerae O Group 1 or Vibrio cholerae O1
and O139.
b. Resistance -
V. cholerae are killed within 30 minutes by heating at 56
deg.C or within a few seconds by boiling.
They remain in ice for 4-6 weeks or longer.
Drying and sunshine will kill them in a few hours.
They are easily destroyed by coal tar disinfectants such
as cresol.
Bleaching powder is another good disinfectant which
kills vibrios instantly at 6 mg/litre. 4
Dr. Shubhangi Kshirsagar
c. Toxin production
The vibrios multiply in the lumen of the small intestine
and produce an exotoxin (enterotoxin).
This toxin produces diarrhoea through its effect on the
adenylate cyclase-cyclic AMP system of mucosal cells
of the small intestine.
5
Dr. Shubhangi Kshirsagar
d. Reservoir of infection – only human - case or carrier.
i. Cases –
Cases range from inapparent infections to severe ones.
About 75 % of people infected with V. cholerae do not
develop any symptoms, although the bacteria are present
in their faeces for 7-14 days after infection and are shed
back into the environment, potentially infecting other
people.
Among people who develop symptoms, about 20 %
develop acute watery diarrhoea with severe dehydration.
ii. Carriers - usually temporary, rarely chronic.
6
Dr. Shubhangi Kshirsagar
e. Infective material
Stools and vomit of cases and carriers.
Large numbers of vibrios (about 107-109 vibrios per ml of
fluid) are present in the watery stools of cholera patients.
Average patient excretes 10-20 litres of fluid.
Carriers excrete fewer vibrios than cases, 102-105 vibrios per
gram of stools.
f. Infective dose
Infection occurs when the number of vibrios ingested
exceeds the dose that is infective for the individual.
In the normal person a very high dose-something like 1011
organisms - is required to produce the clinical disease. 7
Dr. Shubhangi Kshirsagar
g. Period of communicability
A case of cholera is infectious for a period of 7-10 days.
Convalescent carriers are infectious for
2-3 weeks.
The chronic carrier state may last from a month
up to 10 years or more.
8
Dr. Shubhangi Kshirsagar
Host factors
a. Age & sex - affects all ages and both sexes.
In endemic areas, attack rate is highest in children.
b. Gastric acidity - The vibrio is destroyed in an acidity
of pH 5 or lower.
c. Population mobility – Movement of population (e.g.
pilgrimages, marriages, fairs and festivals) results in
increased risk of exposure to infection.
d. Economic status - highest in the lower socio-
economic groups
e. Immunity - Vaccination gives temporary , partial
immunity for 3-6 months. 9
Dr. Shubhangi Kshirsagar
Environmental factors
1. Poor environmental sanitation
2. Contaminated water & food
3. Flies may carry vibrio, but not vector
4. Social factors
Low standard personal hygiene
Lack of education
Poor quality of life
Human habits –favoring water and soil pollution
10
Dr. Shubhangi Kshirsagar
Mode of transmission
1. Faecally contaminated water
2. Contaminated food & drinks
Bottle feeding - significant risk factor for infant
Foods and vegetables washed with contaminated water can
be a source of infection
After preparation, cooked food may be contaminated through
contaminated hands & flies.
3. Direct contact
Person to person transmission through contaminated fingers
while carelessly handling excreta & vomit of patient and
contaminated linens & fomites. 11
Dr. Shubhangi Kshirsagar
Incubation period
Few hours to 5 days
But commonly 1-2 days
12
Dr. Shubhangi Kshirsagar
Clinical features
1. Stage of Evacuation
2. Stage of Collapse
3. Stage of Recovery
Typical case of cholera consist of following stages -
13
Clinical features
1. Stage of evacuation
The onset is abrupt with profuse, painless, watery
diarrhoea followed by vomiting.
The patient may pass as many as 40 stools in a day.
The stools may have a “rice water” appearance.
14
Dr. Shubhangi Kshirsagar
2. Stage of collapse
The patient soon passes into a stage of collapse because of
dehydration.
The classical signs are –
Sunken eyes
Hollow cheeks
Scaphoid abdomen
Sub-normal temperature, pulse absent
Washerman's hands and feet
Unrecordable blood pressure
Loss of skin elasticity
Shallow and quick respirations
Output of urine decreases and may ultimately cease
Patient becomes restless, complains of intense thirst and
cramps in legs and abdomen.
Death may occur at this stage, due to dehydration and
acidosis resulting from diarrhoea.
15
3. Stage of recovery
If death does not occur, the patient begins to show signs
of clinical improvement.
The blood pressure begins to rise, the temperature returns
to normal, and urine secretion is re-established.
If anuria persists, the patient may die of renal failure.
16
Dr. Shubhangi Kshirsagar
Laboratory diagnosis
1. Collection of stools
Fresh specimen of stool should be collected
Collection before the person is treated with antibiotics.
Specimen is collected in following ways –
a. Rubber catheter method
b. Rectal swab
2. Vomitus
3. Water – suspect water collection
4. Suspected food samples 1-3gm (contaminated with V.
Cholarae)
5. Transportation - stool should be transported
in sterilized McCartney bottles, 30 ml capacity containing
alkaline peptone water or VR medium.
17
6. Direct examination – in the dark field, the vibrios evoke
the image of many shooting stars in a dark sky.
7. Culture method
18
Dr. Shubhangi Kshirsagar
Control of Cholera
"Guidelines for Cholera Control" proposed by the WHO
are -
1. Verification of the diagnosis
2. Notification
3. Early case finding
4. Establishment of treatment centers
5. Rehydration therapy
6. Adjuncts to therapy
7. Epidemiological investigations
8. Sanitation measures
9. Chemoprophylaxis
10. Vaccination 19
Dr. Shubhangi Kshirsagar
Control of Cholera
1. Verification of the diagnosis
It is important for confirmation of the outbreak as
quickly as possible.
All cases of diarrhoea should be investigated
For the specific diagnosis of cholera, it is
important to identify V. cholerae 01 in the stools of
the patient.
Once the presence of cholera has been proved, it is
not necessary to culture stools of all cases or
contacts.
20
Dr. Shubhangi Kshirsagar
2. Notification
Cholera is a notifiable disease locally and nationally.
Since 2005 cholera notification is no ·longer mandatory
internationally.
Under the International Health Regulations,
cholera is notifiable to the WHO within 24 hours of its
occurrence by the National Government.
The number of cases and deaths are also to be reported
daily and weekly till the area is declared free of cholera.
An area is declared free of cholera when twice the
incubation period (i.e., 10 days) has elapsed since the death,
recovery or isolation of the last case.
21
Dr. Shubhangi Kshirsagar
3. Early case-finding
An aggressive search for cases (mild, moderate,
severe) should be made in the community to be able
to initiate prompt treatment.
22
Dr. Shubhangi Kshirsagar
4. Establishment of treatment centres
The mildly dehydrated patients should be treated at home with
oral rehydration fluid.
Severely dehydrated patients, requiring
intravenous fluids, should be transferred to the nearest
treatment centre or hospital.
If possible, they should receive oral rehydration on the way to
the hospital or treatment centre.
If there is no hospital or treatment centre within a
convenient distance, a local school or public building should be
taken over and converted into a temporary treatment centre.
In areas where peripheral health services are poor and
cholera is endemic or threatening, mobile teams should be
established at the district level 23
Dr. Shubhangi Kshirsagar
5. Rehydration therapy - may be oral or intravenous.
6. Adjuncts to therapy
Antibiotics should be given as soon as vomiting has
stopped, which is usually after 3 to 4 hours of oral
rehydration.
Injectable antibiotics, have no special advantages.
The commonly used antibiotics for the treatment of
cholera are flouroquinolones, tetracycline,
Azithromycin, ampicilline and Trimethoprim TMP
Sulfamethoxazole (SMX).
No other medication should be given to treat cholera,
like antidiarrhoeals, antiemetics.
24
Dr. Shubhangi Kshirsagar
7. Epidemiological investigations
At the same time, epidemiological studies must be
undertaken to define the extent of the outbreak and
identify the modes of transmission, so that more effective
and specific control measures can be applied.
25
Dr. Shubhangi Kshirsagar
8. Sanitation measures
a. Water control
Provision of piped water supply
In rural areas, water can be made safe by boiling or by
chlorination
b. Excreta disposal
Provision of sanitary latrines
Importance of hand washing with soap after
defecation
c. Food sanitation
d. Disinfection 26
Dr. Shubhangi Kshirsagar
9. Chemoprophylaxis
Studies have shown that approximately 10-12 per cent of
close household contacts of a cholera case may be
bacteriologically positive, and some of these develop
clinical illness.
In contrast, a very small proportion (0.6-1 per cent)
in the community may be excreting vibrios.
Mass chemoprophylaxis is not advised for the total
community.
Tetracycline is the drug of choice for chemoprophylaxis.
27
Dr. Shubhangi Kshirsagar
10. Vaccination
1. Dukoral (WC-rBS)
2. Sanchol and mORCVAX
28
Dr. Shubhangi Kshirsagar
11. Health education
It should be directed mainly to -
Effectiveness and simplicity of oral rehydration
therapy
Benefits of early reporting for prompt treatment
Food hygiene practices
Hand washing after defecation and before eating
Benefit of cooked, hot foods and safe water
29
Dr. Shubhangi Kshirsagar
Thank You !
30

More Related Content

What's hot (20)

Japanese encephalitis epidemiology
Japanese encephalitis epidemiologyJapanese encephalitis epidemiology
Japanese encephalitis epidemiology
 
Influenza
Influenza Influenza
Influenza
 
Plague.pptx
Plague.pptxPlague.pptx
Plague.pptx
 
Epidemiology of malaria
Epidemiology of malariaEpidemiology of malaria
Epidemiology of malaria
 
Plague
Plague Plague
Plague
 
cholera
choleracholera
cholera
 
Cholera - Epidemiology and Prevention
Cholera - Epidemiology and PreventionCholera - Epidemiology and Prevention
Cholera - Epidemiology and Prevention
 
Filariasis
Filariasis�Filariasis�
Filariasis
 
Dengue epidemiology
Dengue epidemiologyDengue epidemiology
Dengue epidemiology
 
acute respiratory tract infection
acute respiratory tract infectionacute respiratory tract infection
acute respiratory tract infection
 
Acute respiratory infection (ARI)
Acute respiratory infection (ARI)Acute respiratory infection (ARI)
Acute respiratory infection (ARI)
 
Malaria (Everything about it)
Malaria (Everything about it)Malaria (Everything about it)
Malaria (Everything about it)
 
Plague disease
Plague diseasePlague disease
Plague disease
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
EPIDEMIOLOGY OF FILARIASIS
EPIDEMIOLOGY OF FILARIASISEPIDEMIOLOGY OF FILARIASIS
EPIDEMIOLOGY OF FILARIASIS
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
cholera
choleracholera
cholera
 
Cholera in community health nursing
Cholera in community health nursingCholera in community health nursing
Cholera in community health nursing
 
Cholera
CholeraCholera
Cholera
 
Dynamics of disease transmission
Dynamics of disease transmissionDynamics of disease transmission
Dynamics of disease transmission
 

Similar to Epidemiology of Cholera

Social and preventive diseases- CHOLERA.pptx
Social and preventive diseases- CHOLERA.pptxSocial and preventive diseases- CHOLERA.pptx
Social and preventive diseases- CHOLERA.pptxAlkaGupta752324
 
Epidemiology of cholera
Epidemiology of choleraEpidemiology of cholera
Epidemiology of choleraNamita Batra
 
Cholera Eltor
Cholera EltorCholera Eltor
Cholera EltorLean
 
COMMUNICABLE DISEASES - MED SURG (present 2nd year).pptx
COMMUNICABLE DISEASES - MED SURG (present 2nd year).pptxCOMMUNICABLE DISEASES - MED SURG (present 2nd year).pptx
COMMUNICABLE DISEASES - MED SURG (present 2nd year).pptxAmresh Kushwaha
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid feverAli Najat
 
Diseases Affecting the Gastro-Intestinal System LECTURE 3.pptx
Diseases Affecting the Gastro-Intestinal System LECTURE 3.pptxDiseases Affecting the Gastro-Intestinal System LECTURE 3.pptx
Diseases Affecting the Gastro-Intestinal System LECTURE 3.pptxOsmanHassan35
 
FECAL ORAL DISEASES.pptx
FECAL ORAL DISEASES.pptxFECAL ORAL DISEASES.pptx
FECAL ORAL DISEASES.pptxSadikHassan4
 
Cholera in Pakistan by Prof Taffazul Zaidi 2018.ppt
Cholera in Pakistan by Prof Taffazul Zaidi 2018.pptCholera in Pakistan by Prof Taffazul Zaidi 2018.ppt
Cholera in Pakistan by Prof Taffazul Zaidi 2018.pptMuhammad Majeed
 
Chapter three fecal oral transmitted diseases
Chapter three fecal oral transmitted diseasesChapter three fecal oral transmitted diseases
Chapter three fecal oral transmitted diseasesAhmed Batun
 
Ofooni1_09_Cholera_Campylobacter.ppt
Ofooni1_09_Cholera_Campylobacter.pptOfooni1_09_Cholera_Campylobacter.ppt
Ofooni1_09_Cholera_Campylobacter.pptAliAmrollahzade
 

Similar to Epidemiology of Cholera (20)

Social and preventive diseases- CHOLERA.pptx
Social and preventive diseases- CHOLERA.pptxSocial and preventive diseases- CHOLERA.pptx
Social and preventive diseases- CHOLERA.pptx
 
Epidemiology of cholera
Epidemiology of choleraEpidemiology of cholera
Epidemiology of cholera
 
Cholera Eltor
Cholera EltorCholera Eltor
Cholera Eltor
 
COMMUNICABLE DISEASES - MED SURG (present 2nd year).pptx
COMMUNICABLE DISEASES - MED SURG (present 2nd year).pptxCOMMUNICABLE DISEASES - MED SURG (present 2nd year).pptx
COMMUNICABLE DISEASES - MED SURG (present 2nd year).pptx
 
Cholera
CholeraCholera
Cholera
 
cholera.ppt
cholera.pptcholera.ppt
cholera.ppt
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Diseases Affecting the Gastro-Intestinal System LECTURE 3.pptx
Diseases Affecting the Gastro-Intestinal System LECTURE 3.pptxDiseases Affecting the Gastro-Intestinal System LECTURE 3.pptx
Diseases Affecting the Gastro-Intestinal System LECTURE 3.pptx
 
CHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal diseaseCHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal disease
 
Cholera and other vibrios
Cholera and other vibriosCholera and other vibrios
Cholera and other vibrios
 
2
22
2
 
cholera and diarrhoea
cholera and diarrhoeacholera and diarrhoea
cholera and diarrhoea
 
FECAL ORAL DISEASES.pptx
FECAL ORAL DISEASES.pptxFECAL ORAL DISEASES.pptx
FECAL ORAL DISEASES.pptx
 
Cholera in Pakistan by Prof Taffazul Zaidi 2018.ppt
Cholera in Pakistan by Prof Taffazul Zaidi 2018.pptCholera in Pakistan by Prof Taffazul Zaidi 2018.ppt
Cholera in Pakistan by Prof Taffazul Zaidi 2018.ppt
 
Cholera
CholeraCholera
Cholera
 
Module v Environmental Sanitation
Module v Environmental SanitationModule v Environmental Sanitation
Module v Environmental Sanitation
 
CCHF case.pptx
CCHF case.pptxCCHF case.pptx
CCHF case.pptx
 
Chapter three fecal oral transmitted diseases
Chapter three fecal oral transmitted diseasesChapter three fecal oral transmitted diseases
Chapter three fecal oral transmitted diseases
 
Ofooni1_09_Cholera_Campylobacter.ppt
Ofooni1_09_Cholera_Campylobacter.pptOfooni1_09_Cholera_Campylobacter.ppt
Ofooni1_09_Cholera_Campylobacter.ppt
 
Shigellosis
ShigellosisShigellosis
Shigellosis
 

More from Dr Shubhangi (Kshirsagar) Hedau

Immunizing agents vaccines, immunoglobulines and antisera
Immunizing agents   vaccines, immunoglobulines and antiseraImmunizing agents   vaccines, immunoglobulines and antisera
Immunizing agents vaccines, immunoglobulines and antiseraDr Shubhangi (Kshirsagar) Hedau
 

More from Dr Shubhangi (Kshirsagar) Hedau (20)

RNTCP programme.pdf
RNTCP programme.pdfRNTCP programme.pdf
RNTCP programme.pdf
 
National Leprosy Eradication programme.pdf
National Leprosy Eradication programme.pdfNational Leprosy Eradication programme.pdf
National Leprosy Eradication programme.pdf
 
World health organisation.pdf
World health organisation.pdfWorld health organisation.pdf
World health organisation.pdf
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Lymphatic filariasis
Lymphatic filariasisLymphatic filariasis
Lymphatic filariasis
 
Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS)Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS)
 
Pertusis ( Whooping Cough)
Pertusis ( Whooping Cough)Pertusis ( Whooping Cough)
Pertusis ( Whooping Cough)
 
Diptheria
DiptheriaDiptheria
Diptheria
 
Mumps
MumpsMumps
Mumps
 
Measles
Measles Measles
Measles
 
Vital statistics health statistics
Vital statistics   health statisticsVital statistics   health statistics
Vital statistics health statistics
 
Epidemiology of chickenpox
Epidemiology of chickenpoxEpidemiology of chickenpox
Epidemiology of chickenpox
 
Epidemiology of tuberculosis
Epidemiology of tuberculosisEpidemiology of tuberculosis
Epidemiology of tuberculosis
 
Concept & levels of prevention
Concept & levels of preventionConcept & levels of prevention
Concept & levels of prevention
 
Immunizing agents vaccines, immunoglobulines and antisera
Immunizing agents   vaccines, immunoglobulines and antiseraImmunizing agents   vaccines, immunoglobulines and antisera
Immunizing agents vaccines, immunoglobulines and antisera
 
Disinfection
DisinfectionDisinfection
Disinfection
 
Modes of intervention
Modes of interventionModes of intervention
Modes of intervention
 
Concpt & levels of prevention
Concpt & levels of preventionConcpt & levels of prevention
Concpt & levels of prevention
 
Immunity host defences
Immunity   host defencesImmunity   host defences
Immunity host defences
 
Epidemiology of leprosy
Epidemiology of leprosyEpidemiology of leprosy
Epidemiology of leprosy
 

Recently uploaded

DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxdrwaque
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...Catherine Liao
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramLevi Shapiro
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Dr. Aryan (Anish Dhakal)
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...kevinkariuki227
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Catherine Liao
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Catherine Liao
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Catherine Liao
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxgauripg8
 
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLSlakehe2738
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...Catherine Liao
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfDr Jeenal Mistry
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesTina Purnat
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyDr KHALID B.M
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feeldranji1
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdfKs doctor
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1DR SETH JOTHAM
 

Recently uploaded (20)

DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)#  Jaipur #𝕔ALL #𝕘IRLS
𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 

Epidemiology of Cholera

  • 1. Cholera Dr. Shubhangi S. Kshirsagar Assistant professor Department of Swasthavritta & Yoga drssksagar@gmail.com
  • 2. Cholera is an acute diarrhoeal disease caused by V. Cholerae O1 (classical or El Tor} and O139. It is now commonly due to the El Tor biotype and O139. Cases range from symptomless to severe infections. The majority of infections are mild or asymptomatic. Typical cases are characterized by the sudden onset of profuse, effortless, watery diarrhoea followed by vomiting, rapid dehydration, muscular cramps and suppression of urine. Cholera 2 Dr. Shubhangi Kshirsagar
  • 4. 1. Agent factors a. Agent - V. cholerae O Group 1 or Vibrio cholerae O1 and O139. b. Resistance - V. cholerae are killed within 30 minutes by heating at 56 deg.C or within a few seconds by boiling. They remain in ice for 4-6 weeks or longer. Drying and sunshine will kill them in a few hours. They are easily destroyed by coal tar disinfectants such as cresol. Bleaching powder is another good disinfectant which kills vibrios instantly at 6 mg/litre. 4 Dr. Shubhangi Kshirsagar
  • 5. c. Toxin production The vibrios multiply in the lumen of the small intestine and produce an exotoxin (enterotoxin). This toxin produces diarrhoea through its effect on the adenylate cyclase-cyclic AMP system of mucosal cells of the small intestine. 5 Dr. Shubhangi Kshirsagar
  • 6. d. Reservoir of infection – only human - case or carrier. i. Cases – Cases range from inapparent infections to severe ones. About 75 % of people infected with V. cholerae do not develop any symptoms, although the bacteria are present in their faeces for 7-14 days after infection and are shed back into the environment, potentially infecting other people. Among people who develop symptoms, about 20 % develop acute watery diarrhoea with severe dehydration. ii. Carriers - usually temporary, rarely chronic. 6 Dr. Shubhangi Kshirsagar
  • 7. e. Infective material Stools and vomit of cases and carriers. Large numbers of vibrios (about 107-109 vibrios per ml of fluid) are present in the watery stools of cholera patients. Average patient excretes 10-20 litres of fluid. Carriers excrete fewer vibrios than cases, 102-105 vibrios per gram of stools. f. Infective dose Infection occurs when the number of vibrios ingested exceeds the dose that is infective for the individual. In the normal person a very high dose-something like 1011 organisms - is required to produce the clinical disease. 7 Dr. Shubhangi Kshirsagar
  • 8. g. Period of communicability A case of cholera is infectious for a period of 7-10 days. Convalescent carriers are infectious for 2-3 weeks. The chronic carrier state may last from a month up to 10 years or more. 8 Dr. Shubhangi Kshirsagar
  • 9. Host factors a. Age & sex - affects all ages and both sexes. In endemic areas, attack rate is highest in children. b. Gastric acidity - The vibrio is destroyed in an acidity of pH 5 or lower. c. Population mobility – Movement of population (e.g. pilgrimages, marriages, fairs and festivals) results in increased risk of exposure to infection. d. Economic status - highest in the lower socio- economic groups e. Immunity - Vaccination gives temporary , partial immunity for 3-6 months. 9 Dr. Shubhangi Kshirsagar
  • 10. Environmental factors 1. Poor environmental sanitation 2. Contaminated water & food 3. Flies may carry vibrio, but not vector 4. Social factors Low standard personal hygiene Lack of education Poor quality of life Human habits –favoring water and soil pollution 10 Dr. Shubhangi Kshirsagar
  • 11. Mode of transmission 1. Faecally contaminated water 2. Contaminated food & drinks Bottle feeding - significant risk factor for infant Foods and vegetables washed with contaminated water can be a source of infection After preparation, cooked food may be contaminated through contaminated hands & flies. 3. Direct contact Person to person transmission through contaminated fingers while carelessly handling excreta & vomit of patient and contaminated linens & fomites. 11 Dr. Shubhangi Kshirsagar
  • 12. Incubation period Few hours to 5 days But commonly 1-2 days 12 Dr. Shubhangi Kshirsagar
  • 13. Clinical features 1. Stage of Evacuation 2. Stage of Collapse 3. Stage of Recovery Typical case of cholera consist of following stages - 13
  • 14. Clinical features 1. Stage of evacuation The onset is abrupt with profuse, painless, watery diarrhoea followed by vomiting. The patient may pass as many as 40 stools in a day. The stools may have a “rice water” appearance. 14 Dr. Shubhangi Kshirsagar
  • 15. 2. Stage of collapse The patient soon passes into a stage of collapse because of dehydration. The classical signs are – Sunken eyes Hollow cheeks Scaphoid abdomen Sub-normal temperature, pulse absent Washerman's hands and feet Unrecordable blood pressure Loss of skin elasticity Shallow and quick respirations Output of urine decreases and may ultimately cease Patient becomes restless, complains of intense thirst and cramps in legs and abdomen. Death may occur at this stage, due to dehydration and acidosis resulting from diarrhoea. 15
  • 16. 3. Stage of recovery If death does not occur, the patient begins to show signs of clinical improvement. The blood pressure begins to rise, the temperature returns to normal, and urine secretion is re-established. If anuria persists, the patient may die of renal failure. 16 Dr. Shubhangi Kshirsagar
  • 17. Laboratory diagnosis 1. Collection of stools Fresh specimen of stool should be collected Collection before the person is treated with antibiotics. Specimen is collected in following ways – a. Rubber catheter method b. Rectal swab 2. Vomitus 3. Water – suspect water collection 4. Suspected food samples 1-3gm (contaminated with V. Cholarae) 5. Transportation - stool should be transported in sterilized McCartney bottles, 30 ml capacity containing alkaline peptone water or VR medium. 17
  • 18. 6. Direct examination – in the dark field, the vibrios evoke the image of many shooting stars in a dark sky. 7. Culture method 18 Dr. Shubhangi Kshirsagar
  • 19. Control of Cholera "Guidelines for Cholera Control" proposed by the WHO are - 1. Verification of the diagnosis 2. Notification 3. Early case finding 4. Establishment of treatment centers 5. Rehydration therapy 6. Adjuncts to therapy 7. Epidemiological investigations 8. Sanitation measures 9. Chemoprophylaxis 10. Vaccination 19 Dr. Shubhangi Kshirsagar
  • 20. Control of Cholera 1. Verification of the diagnosis It is important for confirmation of the outbreak as quickly as possible. All cases of diarrhoea should be investigated For the specific diagnosis of cholera, it is important to identify V. cholerae 01 in the stools of the patient. Once the presence of cholera has been proved, it is not necessary to culture stools of all cases or contacts. 20 Dr. Shubhangi Kshirsagar
  • 21. 2. Notification Cholera is a notifiable disease locally and nationally. Since 2005 cholera notification is no ·longer mandatory internationally. Under the International Health Regulations, cholera is notifiable to the WHO within 24 hours of its occurrence by the National Government. The number of cases and deaths are also to be reported daily and weekly till the area is declared free of cholera. An area is declared free of cholera when twice the incubation period (i.e., 10 days) has elapsed since the death, recovery or isolation of the last case. 21 Dr. Shubhangi Kshirsagar
  • 22. 3. Early case-finding An aggressive search for cases (mild, moderate, severe) should be made in the community to be able to initiate prompt treatment. 22 Dr. Shubhangi Kshirsagar
  • 23. 4. Establishment of treatment centres The mildly dehydrated patients should be treated at home with oral rehydration fluid. Severely dehydrated patients, requiring intravenous fluids, should be transferred to the nearest treatment centre or hospital. If possible, they should receive oral rehydration on the way to the hospital or treatment centre. If there is no hospital or treatment centre within a convenient distance, a local school or public building should be taken over and converted into a temporary treatment centre. In areas where peripheral health services are poor and cholera is endemic or threatening, mobile teams should be established at the district level 23 Dr. Shubhangi Kshirsagar
  • 24. 5. Rehydration therapy - may be oral or intravenous. 6. Adjuncts to therapy Antibiotics should be given as soon as vomiting has stopped, which is usually after 3 to 4 hours of oral rehydration. Injectable antibiotics, have no special advantages. The commonly used antibiotics for the treatment of cholera are flouroquinolones, tetracycline, Azithromycin, ampicilline and Trimethoprim TMP Sulfamethoxazole (SMX). No other medication should be given to treat cholera, like antidiarrhoeals, antiemetics. 24 Dr. Shubhangi Kshirsagar
  • 25. 7. Epidemiological investigations At the same time, epidemiological studies must be undertaken to define the extent of the outbreak and identify the modes of transmission, so that more effective and specific control measures can be applied. 25 Dr. Shubhangi Kshirsagar
  • 26. 8. Sanitation measures a. Water control Provision of piped water supply In rural areas, water can be made safe by boiling or by chlorination b. Excreta disposal Provision of sanitary latrines Importance of hand washing with soap after defecation c. Food sanitation d. Disinfection 26 Dr. Shubhangi Kshirsagar
  • 27. 9. Chemoprophylaxis Studies have shown that approximately 10-12 per cent of close household contacts of a cholera case may be bacteriologically positive, and some of these develop clinical illness. In contrast, a very small proportion (0.6-1 per cent) in the community may be excreting vibrios. Mass chemoprophylaxis is not advised for the total community. Tetracycline is the drug of choice for chemoprophylaxis. 27 Dr. Shubhangi Kshirsagar
  • 28. 10. Vaccination 1. Dukoral (WC-rBS) 2. Sanchol and mORCVAX 28 Dr. Shubhangi Kshirsagar
  • 29. 11. Health education It should be directed mainly to - Effectiveness and simplicity of oral rehydration therapy Benefits of early reporting for prompt treatment Food hygiene practices Hand washing after defecation and before eating Benefit of cooked, hot foods and safe water 29 Dr. Shubhangi Kshirsagar